Whilst these price targets seem wildly high at first glance,...

Whilst these price targets seem wildly high at first glance, they actually seem absurdly low when you really research the AMD market and some of the players in it. The ASX doesn’t offer much in the way of ophthalmology stocks so I guess it’s rather unfamiliar with them, but OPT (assuming the result is good) is easily a $10-$20 stock in the making IMO, likely even higher. You can’t forget how much patent life is remaining, that’s massive earnings for many years to come

Thats enough speculating though! Let’s wait till we have the results before we start getting too excited about price targets